Episode 423: Angiogenesis 2024 Recap with Dr. Philip Rosenfeld Including Discussion of Imaging for AMD, Geographic Atrophy Treatment Benefits and Risks, and More

Dr. Philip Rosenfeld joins to discuss the Angiogenesis 2024 meeting, with topics covered including imaging breakthroughs for age-related macular degeneration, geographic atrophy treatment benefits and risks, and the importance of molarity in assessing efficacy and safety of intravitreal agents.

Relevant Financial Disclosures: Dr. Rosenfeld has consulted for Apellis, Regeneron and Zeiss. Dr. Sridhar has consulted for Apellis, Genentech, Iveric, and Regeneron.

You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Note that on March 14th, 2024: A consulting disclosure for Apellis for Dr. Rosenfeld was addended to this posting